Clinical Trials Browser

Recruiting × Recurrence × CPX-351 × Clear all

NCT03826992 2026-02-18

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute